Early test: checking safety of new cholesterol drug combo
NCT ID NCT07162441
Summary
This early-stage study aims to understand how two experimental drugs for high cholesterol interact when taken together. It will involve 50 healthy adult volunteers who will take the drugs alone and in combination. The main goal is to check how the body processes the drugs and to monitor for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H plus Yangji Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.